Insider Transactions last 24 months for Vertex Pharmaceuticals Incorporated  -  NSDQ: VRTX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Bozic CarmenEVP and CMO03/27/2026DSDirectCOM2,329$450.95$1,050,262.5533,076
Bozic CarmenEVP and CMO03/13/2026DSDirectCOM2,329$481.79$1,122,088.9135,405
Mckechnie DuncanEVP, Chief Commercial Officer03/11/2026DSDirectCOM2,633$498.42$1,312,339.8612,489
Mckechnie DuncanEVP, Chief Commercial Officer03/04/2026DSDirectCOM2,437$475.30$1,158,306.1015,122
Liu JoyEVP and Chief Legal Officer03/02/2026DSDirectCOM892$495.96$442,396.3222,811
Bozic CarmenEVP and CMO02/27/2026DSDirectCOM2,329$480.31$1,118,641.9937,734
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM1,725$496.95$857,238.7598,278
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM5,995$496.16$2,974,479.20100,003
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM15,580$495.38$7,718,020.40105,998
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM3,498$494.33$1,729,166.34121,578
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM2,520$493.29$1,243,090.80125,076
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM949$491.30$466,243.70127,596
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM2,725$490.54$1,336,721.50128,545
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM460$489.32$225,087.20131,270
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM3,278$488.27$1,600,549.06131,730
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM2,510$487.13$1,222,696.30135,008
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM240$482.84$115,881.60137,518
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM120$481.50$57,780.00137,758
Kewalramani ReshmaCEO & President02/27/2026DSDirectCOM400$479.75$191,900.00137,878
Ambrose KristenSVP & Chief Accounting Officer02/26/2026DSDirectCOM357$483.36$172,559.526,624
Ambrose KristenSVP & Chief Accounting Officer02/25/2026DSDirectCOM223$486.35$108,456.056,981
Atkinson Edward Morrow IiiEVP, Chief Technical Ops. Off.02/25/2026DSDirectCOM668$486.35$324,881.8018,432
Biller JonathanEVP and Chief Legal Officer02/25/2026DSDirectCOM945$486.35$459,600.7513,659
Bunnage Mark E.EVP, Chief Scientific Officer02/25/2026DSDirectCOM620$486.35$301,537.007,284
Mckechnie DuncanEVP, Chief Commercial Officer02/25/2026DSDirectCOM2,410$489.00$1,178,490.0017,559
1   2  3  4  5  6  7  8  9  10  Next Last  You are at page 1 of 13 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel